Inventor · disambiguated record
Martin Stogniew
Also filed as: STOGNIEW MARTIN
49 granted patents·47 pending applications·523 citations·filing 1997–2025
98Inventor score
Files withMEDIMMUNE ONCOLOGY INC17ONCOCEUTICS INC16TRANSCEND THERAPEUTICS INC13VICURON PHARM INC12CHIMERIX INC6
Top patents by PatentIndex Score
96 records- 0194US9376437B27-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, salts thereof and methods of using the same in combination therapyONCOCEUTICS INC·Filed 2014·Granted Jun 28, 2016·11 cites·9 claims
- 0293US7198796B2Antifungal parenteral productsVICURON PHARM INC·Filed 2005·Granted Apr 3, 2007·21 cites·23 claims
- 0392US11707446B2Psychoactive medicines and their use for treating psychiatric and neurological conditions and disordersTRANSCEND THERAPEUTICS INC·Filed 2022·Granted Jul 25, 2023·4 cites·28 claims
- 0492US10172862B2Imipridones for gliomasONCOCEUTICS INC·Filed 2018·Granted Jan 8, 2019·5 cites·9 claims
- 0592US9688679B27-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapyONCOCEUTICS INC·Filed 2014·Granted Jun 27, 2017·7 cites·4 claims
- 0691US2025109133A17-BENZYL-4-(2-METHYLBENZYL)-2,4,6,7,8,9-HEXAHYDROIMIDAZO[l,2-A]PYRIDO[3,4-E] PYRIMIDIN-5 (1 H)-ONE, ANALOGS THEREOF, AND SALTS THEREOF AND METHODS FORTHEIR USE IN THERAPYCHIMERIX INC·Filed 2024·Application pending·0 cites
- 0789US6582735B2Compositions and methods of use for extracts of magnoliaceae plantsNPI LLC·Filed 2001·Granted Jun 24, 2003·49 cites·11 claims
- 0888US6218377B1Methods for the administration of amifostine and related compoundsMEDIMMUNE ONCOLOGY INC·Filed 2000·Granted Apr 17, 2001·22 cites·22 claims
- 0988US2024270746A17-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidaz0[1,2-a]pyrid0[3,4-e] pyrimidin-5 (1 h)-one, analogs thereof, and salts thereof and methods for their use in therapyCHIMERIX INC·Filed 2024·Application pending·0 cites
- 1087US12233046B2Psychoactive medicines and their use for treating psychiatric and neurological conditions and disordersTRANSCEND THERAPEUTICS INC·Filed 2024·Granted Feb 25, 2025·0 cites·29 claims
- 1187US9265765B27-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-A]pyrido[4,3-D]pyrimidin-5(3H)-one, salts thereof and methods of using the same in combination therapyONCOCEUTICS INC·Filed 2014·Granted Feb 23, 2016·10 cites·3 claims
- 1287US5994409AMethods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compoundsUS BIOSCIENCE·Filed 1997·Granted Nov 30, 1999·53 cites·40 claims
- 1386US10456402B27-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapyONCOCEUTICS INC·Filed 2018·Granted Oct 29, 2019·1 cites·2 claims
- 1486US2024216379A17-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidaz0[1,2-a]pyrid0[3,4-e] pyrimidin-5 (1 h)-one, salts thereof and methods of using the same in combination therapyCHIMERIX INC·Filed 2024·Application pending·0 cites
- 1584US11969407B2Psychoactive medicines and their use for treating psychiatric and neurological conditions and disordersTRANSCEND THERAPEUTICS INC·Filed 2023·Granted Apr 30, 2024·0 cites·30 claims
- 1684US10369154B2Imipridones for gliomasONCOCEUTICS INC·Filed 2018·Granted Aug 6, 2019·1 cites·30 claims
- 1784US8143212B2Dalbavancin compositions for treatment of bacterial infectionsSTOGNIEW MARTIN·Filed 2009·Granted Mar 27, 2012·7 cites·16 claims
- 1884US6573253B2Methods for the administration of amifostine and related compoundsMEDIMMUNE ONCOLOGY INC·Filed 2001·Granted Jun 3, 2003·20 cites·39 claims
- 1983US12059402B2Psychoactive medicines and their use for treating psychiatric and neurological conditions and disordersTRANSCEND THERAPEUTICS INC·Filed 2023·Granted Aug 13, 2024·0 cites·13 claims
- 2083US6814987B2Compositions and methods of use for extracts of magnoliaceae plantsNPI LLC·Filed 2003·Granted Nov 9, 2004·19 cites·19 claims
- 2183US2024366613A1Impridones for gliomasONCOCEUTICS INC·Filed 2024·Application pending·0 cites
- 2281US7119061B2Dalbavancin compositions for treatment of bacterial infectionsVICURON PHARM INC·Filed 2004·Granted Oct 10, 2006·11 cites·10 claims
- 2381US6489312B1Pharmaceutical formulations comprising aminoalkyl phosphorothioatesMEDIMMUNE ONCOLOGY INC·Filed 1999·Granted Dec 3, 2002·49 cites·33 claims
- 2481US6258821B1Compositions comprising trimetrexate and methods of their synthesis and useMEDIMMUNE ONCOLOGY INC·Filed 1999·Granted Jul 10, 2001·43 cites·73 claims
- 2580US6239119B1Topical administration of amifostine and related compoundsMEDIMMUNE ONCOLOGY INC·Filed 1999·Granted May 29, 2001·35 cites·5 claims
- 2679US11976068B27-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapyCHIMERIX INC·Filed 2021·Granted May 7, 2024·0 cites·2 claims
- 2779US6900175B2Methods of administering dalbavancin for treatment of bacterial infectionsVICURON PHARM INC·Filed 2003·Granted May 31, 2005·9 cites·22 claims
- 2879US6753323B2Topical administration of amifostine and related compoundsMEDIMMUNE ONCOLOGY INC·Filed 2001·Granted Jun 22, 2004·6 cites·19 claims
- 2978US10953014B27-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapyONCOCEUTICS INC·Filed 2019·Granted Mar 23, 2021·0 cites·2 claims
- 3077US12297220B2Phenethylamines and cathinones precursorsTRANSCEND THERAPEUTICS INC·Filed 2024·Granted May 13, 2025·0 cites·8 claims
- 3177US10266533B27-Benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapyONCOCEUTICS INC·Filed 2017·Granted Apr 23, 2019·1 cites·15 claims
- 3274US9845324B27-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapyONCOCEUTICS INC·Filed 2016·Granted Dec 19, 2017·1 cites·26 claims
- 3374US7115564B2Stable pharmaceutical compositions of dalbavancin and methods of administrationVICURON PHARM INC·Filed 2004·Granted Oct 3, 2006·5 cites·4 claims
- 3474US2024327372A1Preparation of phenethylamines and cathinones and stereoisomers thereof and precursors thereofTRANSCEND THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3574US2024374558A1Preparation of phenethylamines and cathinones and stereoisomers thereof and precursors thereofTRANSCEND THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3673US12343326B2Psychoactive medicines and their use for treating psychiatric and neurological conditions and disordersTRANSCEND THERAPEUTICS INC·Filed 2024·Granted Jul 1, 2025·0 cites·5 claims
- 3773US12102639B2Imipridones for gliomasONCOCEUTICS INC·Filed 2021·Granted Oct 1, 2024·0 cites·19 claims
- 3873US6841545B2Stable amorphous amifostine compositions and methods for the preparation of sameMEDIMMUNE ONCOLOGY INC·Filed 2002·Granted Jan 11, 2005·6 cites·31 claims
- 3973US2021154200A17-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5 (1h)-one, salts thereof and methods of using the same in combination therapyONCOCEUTICS INC·Filed 2021·Application pending·0 cites
- 4072US7151094B2Topical administration of amifostine and related compoundsMEDLMMUNE ONCOLOGY INC·Filed 2004·Granted Dec 19, 2006·4 cites·6 claims
- 4171US6991800B2Antifungal parenteral productsVICURON PHARM INC·Filed 2002·Granted Jan 31, 2006·4 cites·48 claims
- 4271US6384259B1Stable amorphous amifostine compositions and dosage formMEDIMMUNE ONCOLOGY INC·Filed 1999·Granted May 7, 2002·25 cites·29 claims
- 4371US2025255846A1Psychoactive medicines and their use for treating psychiatric and neurological conditions and disordersTRANSCEND THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4470US6576635B2Compositions comprising trimetrexateMEDIMMUNE ONCOLOGY INC·Filed 2001·Granted Jun 10, 2003·1 cites·2 claims
- 4570US6017922AThermally stable trimetrexates and processes for producing the sameUS BIOSCIENCE·Filed 1998·Granted Jan 25, 2000·20 cites·19 claims
- 4670US2009305953A1Dalbavancin compositions for treatment of bacterial infectionsVICURON PHARM INC·Filed 2009·Application pending·0 cites
- 4768US10946022B2Imipridones for gliomasONCOCEUTICS INC·Filed 2019·Granted Mar 16, 2021·0 cites·28 claims
- 4868US8501818B2Stabilized compositions of alkylating agents and methods of using sameALONSO ROBERT·Filed 2010·Granted Aug 6, 2013·1 cites·24 claims
- 4968US2022072001A1G protein-coupled receptor (gpcr) modulation by imipridonesCHIMERIX INC·Filed 2021·Application pending·0 cites
- 5067US2009298748A1Methods of administering dalbavancin for treatment of bacterial infectionsVICURON PHARM INC·Filed 2009·Application pending·0 cites
Showing the top 50 of 96 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Martin Stogniew files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →